NCT02040350View on ClinicalTrials.gov

Is the WHO Recommended Dose of Pralidoxime Effective in the Treatment of Organophosphorus Poisoning?

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

November 30, 2013

Conditions
Deaths
Interventions
DRUG

Pralidoxime

Pralidoxime was compared to placebo to study the effects of the drug on mortatlity

Trial Locations (1)

190006

Sheri kashmir insititute of medical sciences, Srinagar

All Listed Sponsors
lead

Sheri Kashmir Institute of Medical Sciences

OTHER

NCT02040350 - Is the WHO Recommended Dose of Pralidoxime Effective in the Treatment of Organophosphorus Poisoning? | Biotech Hunter | Biotech Hunter